Published in Kidney Int on December 01, 2001
Mediators of inflammation in acute kidney injury. Mediators Inflamm (2010) 2.05
The innate immune response in ischemic acute kidney injury. Clin Immunol (2008) 1.98
Early interleukin 6 production by leukocytes during ischemic acute kidney injury is regulated by TLR4. Kidney Int (2011) 1.63
Pathophysiology of acute kidney injury. Compr Physiol (2012) 1.56
Lymphocytes and ischemia-reperfusion injury. Transplant Rev (Orlando) (2009) 1.38
Toll-like receptor 4 regulates early endothelial activation during ischemic acute kidney injury. Kidney Int (2010) 1.22
Therapeutic translation in acute kidney injury: the epithelial/endothelial axis. J Clin Invest (2014) 1.18
Alteration of microvascular permeability in acute kidney injury. Microvasc Res (2008) 1.06
The E-selectin ligand basigin/CD147 is responsible for neutrophil recruitment in renal ischemia/reperfusion. J Am Soc Nephrol (2009) 0.95
Slit2 prevents neutrophil recruitment and renal ischemia-reperfusion injury. J Am Soc Nephrol (2013) 0.91
Effect of N-desulfated heparin on hepatic/renal ischemia reperfusion injury in rats. World J Gastroenterol (2002) 0.84
Acute kidney injury: a conspiracy of Toll-like receptor 4 on endothelia, leukocytes, and tubules. Pediatr Nephrol (2011) 0.83
The role of innate immunity in donor organ procurement. Semin Immunopathol (2011) 0.83
The multifaceted role of the renal microvasculature during acute kidney injury. Pediatr Nephrol (2015) 0.75
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med (2001) 22.32
Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet (1995) 4.06
Randomized clinical trial of specific lactobacillus and fibre supplement to early enteral nutrition in patients with acute pancreatitis. Br J Surg (2002) 3.81
Myocardial ischemia and reperfusion: a murine model. Am J Physiol (1995) 3.38
Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. Am J Kidney Dis (1998) 3.09
Association between active Wegener's granulomatosis and anticytoplasmic antibodies. Arch Intern Med (1989) 2.94
Identification of the CD4(+) T cell as a major pathogenic factor in ischemic acute renal failure. J Clin Invest (2001) 2.79
Survival of recipients of livers from donation after circulatory death who are relisted and undergo retransplant for graft failure. Am J Transplant (2014) 2.67
Proteinuria, albuminuria, risk, assessment, detection, elimination (PARADE): a position paper of the National Kidney Foundation. Am J Kidney Dis (1999) 2.38
Effect of lipid reduction on the progression of renal disease: a meta-analysis. Kidney Int (2001) 2.35
A scientific registry of transplant recipients bayesian method for identifying underperforming transplant programs. Am J Transplant (2014) 2.35
The evaluation of renal transplant candidates: clinical practice guidelines. Patient Care and Education Committee of the American Society of Transplant Physicians. J Am Soc Nephrol (1995) 2.32
Renal ischemia/reperfusion leads to macrophage-mediated increase in pulmonary vascular permeability. Kidney Int (1999) 2.17
OPTN/SRTR 2013 Annual Data Report: kidney. Am J Transplant (2015) 2.11
Role of the T-cell receptor in kidney ischemia-reperfusion injury. Kidney Int (2006) 2.10
Pharmacokinetics of vancomycin in patients with various degrees of renal function. Antimicrob Agents Chemother (1984) 2.09
OPTN/SRTR 2012 Annual Data Report: kidney. Am J Transplant (2014) 2.01
Pathophysiological role of T lymphocytes in renal ischemia-reperfusion injury in mice. Am J Physiol Renal Physiol (2000) 1.99
Definition of health promotion: Part III: Expanding the definition. Am J Health Promot (1989) 1.95
Synergy between tumour necrosis factor alpha and interleukin-1 in the induction of polymorphonuclear leukocyte migration during inflammation. J Leukoc Biol (1988) 1.92
OPTN/SRTR 2011 Annual Data Report: kidney. Am J Transplant (2013) 1.84
The glomerular mesangium. Kidney Int (1980) 1.83
OPTN/SRTR 2013 Annual Data Report: liver. Am J Transplant (2015) 1.79
A controlled trial of intravenous immunoglobulin G in chronic fatigue syndrome. Am J Med (1990) 1.71
Randomized clinical trial of techniques for closure of the pancreatic remnant following distal pancreatectomy. Br J Surg (2009) 1.69
Relationship between vascular disease and age-associated changes in the human kidney. Kidney Int (1987) 1.68
Role of IL-1 in renal ischemic reperfusion injury. J Am Soc Nephrol (1998) 1.67
Experimental pyelonephritis. XIV. Pyelonephritis in normal mice produced by inoculation of E. coli into the bladder lumen during water diuresis. Yale J Biol Med (1967) 1.67
The laryngeal mask airway and positive-pressure ventilation. Anesthesiology (1994) 1.62
OPTN/SRTR 2012 Annual Data Report: liver. Am J Transplant (2014) 1.59
Mechanism of Escherichia coli alpha-hemolysin-induced injury to isolated renal tubular cells. Am J Pathol (1987) 1.57
Risk factors for cancer in renal transplant recipients. Transplantation (1999) 1.54
Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysis. Ann Intern Med (1993) 1.54
OPTN/SRTR 2011 Annual Data Report: liver. Am J Transplant (2013) 1.48
Evaluation of living renal donors. The current practice of US transplant centers. Transplantation (1995) 1.47
Low-dose combined therapy with fluvastatin and cholestyramine in hyperlipidemic patients. Ann Intern Med (1994) 1.44
The equitable allocation of deceased donor lungs for transplant in children in the United States. Am J Transplant (2013) 1.44
Effect of comorbidity adjustment on CMS criteria for kidney transplant center performance. Am J Transplant (2009) 1.43
Antimicrobial treatment of peritonitis associated with continuous ambulatory peritoneal dialysis. Perit Dial Int (1991) 1.42
A novel IL-18BP ELISA shows elevated serum IL-18BP in sepsis and extensive decrease of free IL-18. Cytokine (2001) 1.41
Bacterial growth and killing in chronic ambulatory peritoneal dialysis fluids. J Clin Microbiol (1984) 1.36
Predicting coronary heart disease after kidney transplantation: Patient Outcomes in Renal Transplantation (PORT) Study. Am J Transplant (2010) 1.36
The losartan renal protection study--rationale, study design and baseline characteristics of RENAAL (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan). J Renin Angiotensin Aldosterone Syst (2000) 1.35
Peritoneal macrophages and opsonins: antibacterial defense in patients undergoing chronic peritoneal dialysis. J Infect Dis (1983) 1.35
Cefotaxime and desacetyl cefotaxime kinetics in renal impairment. Clin Pharmacol Ther (1985) 1.34
Inhibition of the mevalonate pathway: benefits beyond cholesterol reduction? Lancet (1996) 1.34
Solid-organ transplantation in older adults: current status and future research. Am J Transplant (2012) 1.33
Prominent and sustained up-regulation of gp130-signaling cytokines and the chemokine MIP-2 in murine renal ischemia-reperfusion injury. Transplantation (2000) 1.33
Opsonic deficiency of peritoneal dialysis effluent in continuous ambulatory peritoneal dialysis. Kidney Int (1984) 1.29
Proteinuria is a risk factor for mortality over 10 years of follow-up. MRFIT Research Group. Multiple Risk Factor Intervention Trial. Kidney Int Suppl (1997) 1.28
Kidney, pancreas and liver allocation and distribution in the United States. Am J Transplant (2012) 1.24
The influence of age, sex, race, and body habitus on kidney weight in humans. Arch Pathol Lab Med (1986) 1.23
Renal injury of diet-induced hypercholesterolemia in rats. Kidney Int (1990) 1.21
Ethylene glycol poisoning: pharmacokinetics during therapy with ethanol and hemodialysis. N Engl J Med (1981) 1.21
Gas leak and gastric insufflation during controlled ventilation: face mask versus laryngeal mask airway. Can J Anaesth (1998) 1.20
Chronic renal allograft rejection: immunologic and nonimmunologic risk factors. Kidney Int (1996) 1.20
The Zucker rat model of obesity, insulin resistance, hyperlipidemia, and renal injury. Hypertension (1992) 1.20
OPTN/SRTR 2011 Annual Data Report: lung. Am J Transplant (2013) 1.20
Current concepts in the management of peritonitis in patients undergoing continuous ambulatory peritoneal dialysis. Rev Infect Dis (1987) 1.19
Long-term effects of antihypertensive agents on proteinuria and renal function. Arch Intern Med (1995) 1.16
Survival and rehabilitation of patients on home hemodialysis. Five years' experience. Ann Intern Med (1973) 1.13
Pharmacologic treatment of hyperlipidemia reduces glomerular injury in rat 5/6 nephrectomy model of chronic renal failure. Circ Res (1988) 1.13
Bayesian methods for assessing transplant program performance. Am J Transplant (2014) 1.12
IL-1 and TNF independent pathways mediate ICAM-1/VCAM-1 up-regulation in ischemia reperfusion injury. J Leukoc Biol (2001) 1.12
Acute kidney injury and lung dysfunction: a paradigm for remote organ effects of kidney disease? Microvasc Res (2008) 1.12
Physicians' participatory decision-making and quality of diabetes care processes and outcomes: results from the triad study. Chronic Illn (2009) 1.11
Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats. Kidney Int (1988) 1.09
Opioid-mediated suppression of interferon-gamma production by cultured peripheral blood mononuclear cells. J Clin Invest (1987) 1.09
Sunburn. Sci Am (1968) 1.08
Intracellular survival of Candida albicans in peritoneal macrophages from chronic peritoneal dialysis patients. Am J Kidney Dis (1986) 1.08
OPTN/SRTR 2012 Annual Data Report: heart. Am J Transplant (2014) 1.08
OPTN/SRTR 2012 Annual Data Report: lung. Am J Transplant (2014) 1.07
Recurrent respiratory syncytial virus infections in allergen-sensitized mice lead to persistent airway inflammation and hyperresponsiveness. J Immunol (2000) 1.05
Solar Energy. Science (1949) 1.05
Role of VLA-4 and LFA-1 in allergen-induced airway hyperresponsiveness and lung inflammation in the rat. Am J Respir Crit Care Med (1995) 1.04
Enhancement of endotoxin-induced isolated renal tubular cell injury by toxic shock syndrome toxin 1. Am J Pathol (1986) 1.04
Incidence and type of infections occurring in 445 chronic hemodialysis patients. Trans Am Soc Artif Intern Organs (1977) 1.03
Use of cardioprotective medications in kidney transplant recipients. Am J Transplant (2009) 1.03
Recent advances in statins and the kidney. Kidney Int Suppl (1999) 1.01
OPTN/SRTR 2013 Annual Data Report: lung. Am J Transplant (2015) 1.01
The kidney in cardiovascular disease. Ann Intern Med (2001) 1.01
OPTN/SRTR 2013 Annual Data Report: heart. Am J Transplant (2015) 1.00
Patients with a low income have reduced renal allograft survival. Am J Kidney Dis (1992) 1.00
Hyperlipidemia in solid organ transplantation. Transplantation (1997) 0.99
Disposition of gabapentin in anuric subjects on hemodialysis. J Clin Pharmacol (1995) 0.99
Glomerular hemodynamic and structural alterations in experimental diabetes mellitus. FASEB J (1988) 0.98
Opioid peptides rapidly stimulate superoxide production by human polymorphonuclear leukocytes and macrophages. Endocrinology (1985) 0.98
Determination of residual renal function with iohexol clearance in hemodialysis patients. Kidney Int (1996) 0.98
Opioid-mediated suppression of cultured peripheral blood mononuclear cell respiratory burst activity. J Immunol (1987) 0.98
Unilateral Shwartzman reaction: cortical necrosis in one kidney following in vivo perfusion with endotoxin. Kidney Int (1977) 0.98